Literature DB >> 1568165

Quality of care for colorectal cancer in a fee-for-service and health maintenance organization practice.

S W Vernon1, J I Hughes, V M Heckel, G L Jackson.   

Abstract

This study assessed the effectiveness of two types of health plans, offered by the same health care provider, in the diagnosis and treatment of colorectal cancer. Data on 330 cases diagnosed from 1984 through 1989 were abstracted from medical records. Of these, 205 (62%) used fee-for-service (FFS) and 125 (38%) used health maintenance organization (HMO) plans. Overall, there were no differences between FFS and HMO cases for duration of symptoms before diagnosis, training of physician who diagnosed the tumor, anatomic location of the tumor, type of primary treatment, Dukes' stage at final diagnosis, or survival. There were differences between the groups for age, presence of symptoms at diagnosis, time from detection to treatment, and method of detection. Cox regression analysis showed no difference in survival by type of health plan before or after adjusting for age and stage at diagnosis. The findings from this study are consistent with those from studies reporting little or no difference in the process or outcome of care for patients with different types of medical insurance coverage.

Entities:  

Mesh:

Year:  1992        PMID: 1568165     DOI: 10.1002/1097-0142(19920515)69:10<2418::aid-cncr2820691006>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Managed care plan performance since 1980: another look at 2 literature reviews.

Authors:  K Sullivan
Journal:  Am J Public Health       Date:  1999-07       Impact factor: 9.308

2.  Physician remuneration methods for family physicians in Canada: expected outcomes and lessons learned.

Authors:  Dominika W Wranik; Martine Durier-Copp
Journal:  Health Care Anal       Date:  2009-01-27

3.  Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.

Authors:  Polina Khrizman; Joyce C Niland; Anna ter Veer; Dana Milne; Kelli Bullard Dunn; William E Carson; Paul F Engstrom; Stephen Shibata; John M Skibber; Martin R Weiser; Deborah Schrag; Al B Benson
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

4.  Effects of health insurance and race on colorectal cancer treatments and outcomes.

Authors:  R G Roetzheim; N Pal; E C Gonzalez; J M Ferrante; D J Van Durme; J P Krischer
Journal:  Am J Public Health       Date:  2000-11       Impact factor: 9.308

5.  Measuring access to effective care among elderly medicare enrollees in managed and Fee-for-Service care: a retrospective cohort study.

Authors:  M B Barton; D A Dayhoff; S B Soumerai; M L Rosenbach; R H Fletcher
Journal:  BMC Health Serv Res       Date:  2001-11-01       Impact factor: 2.655

6.  Racial disparities negatively impact outcomes in early-onset colorectal cancer independent of socioeconomic status.

Authors:  Suneel D Kamath; Nataly Torrejon; Wei Wei; Katherine Tullio; Kanika G Nair; David Liska; Smitha S Krishnamurthi; Alok A Khorana
Journal:  Cancer Med       Date:  2021-10-14       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.